APA (7th ed.) Citation

Xu, Y., Xiao, X., Ma, C., Wang, Z., Feng, W., Rao, H., . . . Li, L. (2024). Epithelial NSD2 maintains FMO‐mediated taurine biosynthesis to prevent intestinal barrier disruption. Clinical & Translational Medicine, 14(12), 1. https://doi.org/10.1002/ctm2.70128

Chicago Style (17th ed.) Citation

Xu, Yue, et al. "Epithelial NSD2 Maintains FMO‐mediated Taurine Biosynthesis to Prevent Intestinal Barrier Disruption." Clinical & Translational Medicine 14, no. 12 (2024): 1. https://doi.org/10.1002/ctm2.70128.

MLA (9th ed.) Citation

Xu, Yue, et al. "Epithelial NSD2 Maintains FMO‐mediated Taurine Biosynthesis to Prevent Intestinal Barrier Disruption." Clinical & Translational Medicine, vol. 14, no. 12, 2024, p. 1, https://doi.org/10.1002/ctm2.70128.